Clinical Trials Directory

Trials / Completed

CompletedNCT01883453

A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold

A Double Blinded Clinical Study Aiming to Shorten an Episode of Common Cold When the Treatment is Started at the Onset of an Episode of Common Cold

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
146 (actual)
Sponsor
Umeå University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Healthy persons are invited to participate in the study and are given a home protocol (WURSS21), nasal spray and a sample pin. The included persons are told to make a nasopharyngeal sampling from the nose when they are sure that they have caught a common cold. After the sampling they start to spray and also fill in the records daily. The aim of the study is to investigate whether a nasal spray with glucose oxidase could shorten an episode of common cold.

Detailed description

Persons working in a military unit in Boden and persons connected to the Department of Sports Medicine in Umeå were invited to participate in this study. Only persons older than 18 years was included in the study. The persons included received one bottle of study medicine, a home protocol (WURSS 21) and a viral sampling kit. Whenever the included persons were sure that they had received an episode of common cold they were told to perform a viral sampling from the nose, fill in the protocol and start to use the nasal spray several times daily for one week. The treatment was either a) a saline solution with 5% glucose or b) a saline solution with 200U/ml of glucose oxidase and 5%glucose (active treatment group). The combination of glucose oxidase and glucose produces an acid environment, imitating the effect of the normal nasal flora and Human Rhinoviruses are sensitive to an acid environment. After one week of treatment and daily records of the WURSS 21 protocol the persons returned the spray bottles (Bag-on-Valve), the virus vials and the protocols. A total of 146 persons were included in the study and 98 persons returned protocols.

Conditions

Interventions

TypeNameDescription
DEVICEGlucose oxidase+5%glucoseA hydrogen peroxide producing enzyme
DEVICESaline+5%glucoseIsotonic saline + 5% glucose in a bag-on-valve nasal spray device

Timeline

Start date
2013-01-01
Primary completion
2013-05-01
Completion
2013-09-01
First posted
2013-06-21
Last updated
2015-11-09
Results posted
2015-11-09

Locations

2 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01883453. Inclusion in this directory is not an endorsement.